Global Implications of Brazil’s Model Most developing countries enjoy much lower prices for the generic drugs Brazil produces locally; generic drug prices are therefore unlikely to contribute to rising costs to the same degree in other places as they have in Brazil. Though Brazil’s initial prices for the newest ARVs may be higher than prices other developing countries ultimately enjoy for the same drugs, by threatening to issue or issuing compulsory licenses and producing drugs locally, Brazil has historically enjoyed